Ocular hypotensive agents

Details Ocular hypotensive agents Ocular hypotensive agents

1991-09-16

1993-05-18

Gerstl, Robert

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514573, A61K 31557

Patent

active

052122000

ABSTRACT:
The present invention relates to ocular hypotensive agents which contains 13,14-dihydro-15-keto-prostagrandins, which shows no transient ocular hypertensive response that PGs usually show.

REFERENCES:
patent: 5073569 (1991-12-01), Ueno
The Journal of Chromatography, vol. 156, 1978, pp. 131-141.
Arch. Int. Pharmacodyn., vol. 207, 1974, pp. 1310138.
Invest, Ophthalmol. Visual Sci., vol. 16, No. 12, Dec. 1977, pp. 1125-1134.
Acta Physiol. Scand., vol. 66, 1966, pp. 509-510.
Exp. Eye. Research 44, 825-837 (1987).
Graef's Arch. Clin. Exp. Ophthalmol. (1985) 222:139-141.
Investigative Ophthalmology and Visual Science by Bito, May 1982, vol. 22, No. 5.

Affiliated with

Also associated with

Rating

Ocular hypotensive agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ocular hypotensive agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular hypotensive agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-804783